सत्याधीशसत्याधीश
SatyaDheesh
India's Ground Truth Record
Pull to refresh
VOL. I · EST. 11.2025 
SatyaDheesh
सत्याधीश
India's Ground Truth Record
LIVE

Over 90% of Indian Candida auris isolates resist azole-based antifungals, study finds

GS3Economy · S&T · Environment · Security· Biotechnology & health research· Prelims + Mains·

Antimicrobial resistance in fungal pathogens: a critical GS3 Science & Technology and Public Health topic.

Why in news

Researchers from JNCASR found that over 90% of Indian *Candida auris* isolates are resistant to azole-based antifungals, posing a significant public health threat.

Background

A study in Nature Communications by researchers from JNCASR identified that *Candida auris* has a 30-40% mortality rate. The study highlighted genetic mutations and the 'Eagle effect' as primary mechanisms for antifungal resistance in Indian isolates.

Facts for Prelims

  • S&TCandida auris: A fungal pathogen with a reported 30-40% mortality rate.
  • FactOver 90% of Indian C. auris isolates are resistant to azole-based antifungals.
  • S&TEagle effect: Identified as a mechanism for antifungal resistance in C. auris.
  • BodyJNCASR: Jawaharlal Nehru Centre for Advanced Scientific Research.

Prelims practice question

With reference to Candida auris and antifungal resistance, consider the following statements:

  1. The mortality rate associated with Candida auris is reported to be between 10-20%.
  2. Over 90% of Indian Candida auris isolates are resistant to azole-based antifungals.
  3. The Eagle effect is identified as a mechanism for antifungal resistance in C. auris.

Which of the statements given above is/are correct?

  1. (a)1 only
  2. (b)1 and 2 only
  3. (c)2 and 3 only
  4. (d)1, 2 and 3
Show answer

Answer: (c) 2 and 3 only — Statements 2 and 3 are correct. Statement 1 is incorrect: The study reports a 30-40% mortality rate.

For Mains

Q. Discuss the growing threat of antimicrobial resistance (AMR) in fungal pathogens and the implications for India's public health infrastructure.

Dimensions to cover in your answer

  • Diagnostic gap: Lack of rapid point-of-care testing for specific fungal species in rural healthcare
  • Therapeutic limitation: Diminishing efficacy of standard azole-based drugs against multi-drug resistant isolates
  • Epidemiological risk: High mortality rates in clinical settings due to rapid fungal spread in immunocompromised patients

Keywords: Antimicrobial Resistance · Fungal Pathogens · Public Health · Genetic Mutation · Eagle Effect

Read the full news →Source: The Hindu ↗Also: GS2 · Health policy & public health

More Science & Technology notes

All Science & Technology current affairs →

This note is generated automatically from SatyaDheesh's news feed and mapped to the UPSC CSE syllabus. Check facts against the original report or PIB before using them in an answer.